Purchase Order HT001423P0165
Award Date
7/14/23
Potential Completion Date
1/19/24
Potential Value
$498K
Federal Agency
Defense Health Agency
Awardee
Sofie CO.
Ultimate Awardee
Sofie Biosciences, Inc.
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20889, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,863,815.56 firm fixed-price definitive contract awarded by the Department of Veterans Affairs (VA) to Sofie CO., doing business as Sofie, for the supply of PYLARIFY (piflufolastat F-18 injection), a radiopharmaceutical used for prostate cancer detection. The contract has an ultimate completion date of December 31, 2025 and was awarded on January 1, 2025 without any set-aside designation. Sofie is a subsidiary of Sofie Biosciences, Inc. and has extensive experience providing...
This is a Firm Fixed Price contract awarded by the Defense Health Agency (DHA) to Sofie CO. (doing business as Sofie), a subsidiary of Sofie Biosciences, Inc. The contract is for the delivery of a radiopharmaceutical needed for prostate cancer patients with metastatic lesions after definitive treatment. The contract has a ceiling value of $32,478.48 and a period of performance through September 30, 2024. This award is not associated with a set-aside program. Sofie CO. is an established...
The U.S. Department of Veterans Affairs (VA) awarded a $75,783.12 firm-fixed-price purchase order contract to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract is for the delivery of PYLARIFY, a radiopharmaceutical used in prostate cancer detection. This contract is part of Sofie's broader supply of specialized imaging agents, pharmaceuticals, and related services to various federal agencies, including the VA, Defense Health Agency, and National Institutes of Health. Sofie has...
This federal contract award to Sofie CO., doing business as Sofie, is for the supply of radiopharmaceuticals required for patient care. The $10,826.16 Firm Fixed Price contract, awarded by the Defense Health Agency (DHA), is a Blanket Purchase Agreement (BPA) call that runs through September 30, 2024. Sofie is an established provider of specialized imaging agents, prostate cancer detection tools, and injectable cancer drugs to various federal agencies, including the Department of Veterans...
This is a firm fixed-price Blanket Purchase Agreement (BPA) call contract awarded by the Defense Health Agency (DHA) to Sofie CO., doing business as Sofie, a subsidiary of Sofie Biosciences, Inc. The $10,826.16 contract is for the supply of a radiopharmaceutical needed for prostate cancer patients with metastatic lesions after definitive treatment. The contract has an ultimate completion date of September 30, 2024. Sofie is a specialized provider of radiopharmaceuticals, pharmaceuticals, and...
This federal contract award to Sofie CO. is for the provision of nuclear medicine PET radioisotopes to the Department of Veterans Affairs (VA) Veterans Health Administration in Veterans Integrated Service Network 21. The $136,876.00 firm-fixed-price purchase order does not have a set-aside designation. Sofie CO. is a for-profit organization that specializes in developing and delivering molecular diagnostics and therapeutics. The company has received numerous federal contract awards from the...
This federal contract award, with an ID of HT001415A0106|0002, was issued by the Defense Health Agency to Sofie CO., doing business as Sofie, a subsidiary of Sofie Biosciences, Inc. The contract, valued at $149,875.00, is a Firm Fixed Price BPA Call order to provide FDG(F18) NAFL(F18) UNIT DOSE/PATIENT services. The contract has a total small business set-aside designation and runs through September 30, 2016. Sofie CO. is a specialized provider of radiopharmaceuticals, pharmaceuticals, and...
This is a federal contract award to Sofie CO., doing business as Sofie, a for-profit organization specializing in the development and delivery of molecular diagnostics and therapeutics. The $80,750 firm fixed-price contract was awarded by the Department of Veterans Affairs (VA) to provide PET (Positron Emission Tomography) pharmaceuticals. The contract is part of the VA's VISN 4 (Veterans Integrated Service Network 4) program and has an ultimate completion date of December 30, 2019. Sofie has...
This is a federal contract award to Sofie CO., doing business as Sofie, for the provision of PET radiopharmaceuticals to the Department of Veterans Affairs (VA). The contract, valued at $77,670.00, is a firm fixed-price purchase order with a completion date of September 30, 2018. Sofie is a subsidiary of Sofie Biosciences, Inc. and specializes in the development and delivery of molecular diagnostics and therapeutics, particularly PET imaging agents and cancer treatment products. The contract...
The U.S. Defense Health Agency awarded a Blanket Purchase Agreement (BPA) call to Sofie CO. for the supply of Fluorodeoxyglucose (F-18 FDG) and Sodium Fluoride (F-18 NAF) radioactive diagnostic agents. The contract has a firm fixed price of $149,940.00 and a completion date of September 30, 2018. Sofie CO. is a for-profit organization that has received numerous federal contract awards from agencies such as the Department of Veterans Affairs and the National Institutes of Health to provide...